Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Prevention of cytomegalovirus disease in renal allograft recipients
H. H. Balfour
Laboratory Medicine and Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prevention of cytomegalovirus disease in renal allograft recipients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Renal Allograft Recipient
100%
Cytomegalovirus Disease
100%
Passive Immunization
25%
High Dose
25%
Cytomegalovirus
25%
Allograft Rejection
25%
Interferon-α (IFN-α)
25%
Medical Expenses
25%
Antiviral Agents
25%
Oral Acyclovir
25%
Superinfection
25%
New Antiviral Agents
25%
Morbidity Mortality
25%
Prophylactic Strategy
25%
Medicine and Dentistry
Kidney Allograft
100%
Cytomegalovirus Infection
100%
Antivirus Agent
50%
Drug Megadose
25%
Graft Rejection
25%
Cytomegalovirus
25%
Superinfection
25%
Passive Immunization
25%
Aciclovir
25%
Interferon
25%
Immunology and Microbiology
Cytomegalovirus
100%
Allograft
100%
Interferon Type I
20%
Transplant Rejection
20%
Drug Megadose
20%
Superinfection
20%